Disease on EC 4.1.1.37 - uroporphyrinogen decarboxylase
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Adrenocortical Carcinoma
Organ porphyrins and uroporphyrinogen decarboxylase activity in a case of non-functioning adrenocortical carcinoma.
Carcinoma
Organ porphyrins and uroporphyrinogen decarboxylase activity in a case of non-functioning adrenocortical carcinoma.
Carcinoma
Uroporphyrinogen decarboxylase from mouse mammary carcinoma and liver of normal and tumor-bearing mouse.
Carcinoma, Renal Cell
Uroporphyrinogen decarboxylase and porphyrins in the tissue of human clear-cell renal carcinoma and in its maternal renal cortex.
Coproporphyria, Hereditary
Alterations in the activity of enzymes of haem biosynthesis in lead poisoning and acute hepatic prophyria.
Deficiency Diseases
Porphyria cutanea tarda, or the uroporphyrinogen decarboxylase deficiency diseases.
Dermatitis
Porphyria cutanea tarda associated with HFE C282Y homozygosity, iron overload, and use of a contraceptive vaginal ring.
Genetic Diseases, Inborn
Identification of a new mutation responsible for hepatoerythropoietic porphyria.
Genetic Diseases, Inborn
Uroporphyrinogen decarboxylase: a splice site mutation causes the deletion of exon 6 in multiple families with porphyria cutanea tarda.
Glioma
TCGA mRNA Expression Analysis of the Heme Biosynthesis Pathway in Diffusely Infiltrating Gliomas: A Comparison of Typically 5-ALA Fluorescent and Non-Fluorescent Gliomas.
Head and Neck Neoplasms
Uroporphyrinogen decarboxylase as a potential target for specific components of traditional Chinese medicine: a virtual screening and molecular dynamics study.
Head and Neck Neoplasms
Uroporphyrinogen decarboxylase is a radiosensitizing target for head and neck cancer.
Head and Neck Neoplasms
Uroporphyrinogen decarboxylase: optimizing radiotherapy for head and neck cancer.
Hemochromatosis
A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda.
Hemochromatosis
Co-inheritance of mutations in the uroporphyrinogen decarboxylase and hemochromatosis genes accelerates the onset of porphyria cutanea tarda.
Hemochromatosis
Decreased hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda.
Hemochromatosis
Familial and sporadic porphyria cutanea tarda: clinical, biochemical and genetic features with emphasis on iron status.
Hemochromatosis
Familial porphyria cutanea tarda: characterization of seven novel uroporphyrinogen decarboxylase mutations and frequency of common hemochromatosis alleles.
Hemochromatosis
Porphyria cutanea tarda, hepatitis C, uroporphyrinogen decarboxylase and mutations of HFE gene. A case-control study.
Hepatitis C
Blistering Disease During the Treatment of Chronic Hepatitis C With Ledipasvir/Sofosbuvir.
Hepatitis C
C282Y and H63D mutation of the hemochromatosis gene in German porphyria cutanea tarda patients.
Hepatitis C
Hemochromatosis gene sequence deviations in German patients with porphyria cutanea tarda.
Hepatitis C
Hepatic porphyrin concentration and uroporphyrinogen decarboxylase activity in hepatitis C virus infection.
Hepatitis C
Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infection.
Hepatitis C
Human immunodeficiency virus and risk of porphyria cutanea tarda: a possible association examined in a large hospital.
Hepatitis C
Porphyria cutanea tarda, hepatitis C, uroporphyrinogen decarboxylase and mutations of HFE gene. A case-control study.
Hepatitis C
Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency.
Hepatitis C
[Acquired characteristics of porphyria cutanea tarda in patients infected with hepatitis C virus]
Hepatitis, Chronic
Decreased hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda.
HIV Infections
Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency.
Hypertrichosis
Two cases of infantile porphyria cutanea tarda: successful treatment with oral S-adenosyl-L-methionine and low-dose oral chloroquine.
Infections
Associations among behavior-related susceptibility factors in porphyria cutanea tarda.
Infections
Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infection.
Iron Overload
Chemically-induced formation of an inhibitor of hepatic uroporphyrinogen decarboxylase in inbred mice with iron overload.
Iron Overload
Dual mechanism of inhibition of rat liver uroporphyrinogen decarboxylase activity by ferrous iron: its potential role in the genesis of porphyria cutanea tarda.
Iron Overload
Hemochromatosis gene sequence deviations in German patients with porphyria cutanea tarda.
Iron Overload
HFE mutations and transferrin receptor polymorphism analysis in porphyria cutanea tarda: a prospective study of 36 cases from southern France.
Iron Overload
High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda.
Iron Overload
Investigations on the role of free radical processes in hexachlorobenzene-induced porphyria in mice.
Iron Overload
Uroporphyria and hepatic carcinogenesis induced by polychlorinated biphenyls-iron interaction: absence in the Cyp1a2(-/-) knockout mouse.
Kidney Failure, Chronic
Decreased uroporphyrinogen decarboxylase activity in patients with end-stage renal disease undergoing hemodialysis.
Liver Diseases
Decreased hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda.
Liver Diseases
Hepatic heme synthesis in a new model of experimental hemochromatosis: studies in rats fed finely divided elemental iron.
Liver Diseases
High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda.
Liver Diseases
[Acquired characteristics of porphyria cutanea tarda in patients infected with hepatitis C virus]
Liver Diseases, Alcoholic
An inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyrinogen decarboxylase activity.
Liver Diseases, Alcoholic
Decreased activity of hepatic uroporphyrinogen decarboxylase in sporadic porphyria cutanea tarda.
Liver Diseases, Alcoholic
Decreased hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda.
Liver Neoplasms
Porphyrins, porphyrin metabolism, porphyrias. III. Diagnosis, care and monitoring in porphyria cutanea tarda--suggestions for a handling programme.
Neoplasm Metastasis
Organ porphyrins and uroporphyrinogen decarboxylase activity in a case of non-functioning adrenocortical carcinoma.
Neoplasms
A possible strategy against head and neck cancer: in silico investigation of three-in-one inhibitors.
Neoplasms
Heme biosynthesis in human breast cancer--mimetic "in vitro" studies and some heme enzymic activity levels.
Neoplasms
TCGA mRNA Expression Analysis of the Heme Biosynthesis Pathway in Diffusely Infiltrating Gliomas: A Comparison of Typically 5-ALA Fluorescent and Non-Fluorescent Gliomas.
Neoplasms
Uroporphyria and hepatic carcinogenesis induced by polychlorinated biphenyls-iron interaction: absence in the Cyp1a2(-/-) knockout mouse.
Neoplasms
Uroporphyrinogen decarboxylase and porphyrins in the tissue of human clear-cell renal carcinoma and in its maternal renal cortex.
Neoplasms
Uroporphyrinogen decarboxylase from mouse mammary carcinoma and liver of normal and tumor-bearing mouse.
Porphyria Cutanea Tarda
A case of porphyria cutanea tarda in the setting of hepatitis C infection and tobacco usage.
Porphyria Cutanea Tarda
A first report of porphyria cutanea tarda successfully treated with glycyrrhizin.
Porphyria Cutanea Tarda
A mutation (G281E) of the human uroporphyrinogen decarboxylase gene causes both hepatoerythropoietic porphyria and overt familial porphyria cutanea tarda: biochemical and genetic studies on Spanish patients.
Porphyria Cutanea Tarda
A point mutation in the coding region of uroporphyrinogen decarboxylase associated with familial porphyria cutanea tarda.
Porphyria Cutanea Tarda
A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda.
Porphyria Cutanea Tarda
A potential biochemical explanation for the genesis of porphyria cutanea tarda. Studies on the inherent biochemical defect in highly purified human erythrocyte uroporphyrinogen decarboxylase and its amplification by iron.
Porphyria Cutanea Tarda
A simplified method for determination of uroporphyrinogen decarboxylase activity in human blood.
Porphyria Cutanea Tarda
Activation of uroporphyrinogen decarboxylase by ferrous iron in porphyria cutanea tarda.
Porphyria Cutanea Tarda
Acute Intermittent Porphyria in a Man with Dual Enzyme Deficiencies.
Porphyria Cutanea Tarda
An inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyrinogen decarboxylase activity.
Porphyria Cutanea Tarda
Analysis of uroporphyrinogen decarboxylase complementary DNAs in sporadic porphyria cutanea tarda.
Porphyria Cutanea Tarda
Associations among behavior-related susceptibility factors in porphyria cutanea tarda.
Porphyria Cutanea Tarda
Bilateral, geographic, peripapillary, chorioretinal atrophy in a patient with porphyria cutanea tarda and high iron stores.
Porphyria Cutanea Tarda
Blistering Disease During the Treatment of Chronic Hepatitis C With Ledipasvir/Sofosbuvir.
Porphyria Cutanea Tarda
C282Y and H63D mutation of the hemochromatosis gene in German porphyria cutanea tarda patients.
Porphyria Cutanea Tarda
Characterization of a new mutation (R292G) and a deletion at the human uroporphyrinogen decarboxylase locus in two patients with hepatoerythropoietic porphyria.
Porphyria Cutanea Tarda
Co-inheritance of mutations in the uroporphyrinogen decarboxylase and hemochromatosis genes accelerates the onset of porphyria cutanea tarda.
Porphyria Cutanea Tarda
Complex gene-chemical interactions: hepatic uroporphyria as a paradigm.
Porphyria Cutanea Tarda
Complex pattern of alternative splicing in the normal uroporphyrinogen decarboxylase gene: implications for diagnosis of familial porphyria cutanea tarda.
Porphyria Cutanea Tarda
Comprehensive cytochrome P450 CYP1A2 gene analysis in French caucasian patients with familial and sporadic porphyria cutanea tarda.
Porphyria Cutanea Tarda
CYP1A2*1F and GSTM1 Alleles Are Associated with Susceptibility to Porphyria Cutanea Tarda.
Porphyria Cutanea Tarda
Cytochrome P450 induction, uroporphyrinogen decarboxylase depression, porphyrin accumulation and excretion, and gender influence in a 3-week rat model of porphyria cutanea tarda.
Porphyria Cutanea Tarda
Decreased activity of hepatic uroporphyrinogen decarboxylase in sporadic porphyria cutanea tarda.
Porphyria Cutanea Tarda
Decreased hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda.
Porphyria Cutanea Tarda
Defective human erythrocyte uroporphyrinogen decarboxylase in familial porphyria cutanea tarda: the metabolic lesion or the result of endogenous porphyrinemia?
Porphyria Cutanea Tarda
Dual mechanism of inhibition of rat liver uroporphyrinogen decarboxylase activity by ferrous iron: its potential role in the genesis of porphyria cutanea tarda.
Porphyria Cutanea Tarda
Effects of polychlorinated biphenyl compounds, 2,3,7,8-tetrachlorodibenzo-p-dioxin, phenobarbital and iron on hepatic uroporphyrinogen decarboxylase. Implications for the pathogenesis of porphyria.
Porphyria Cutanea Tarda
Enzymatic and immunological studies of uroporphyrinogen decarboxylase in familial porphyria cutanea tarda and hepatoerythropoietic porphyria.
Porphyria Cutanea Tarda
Erythrocyte porphobilinogen deaminase activity in porphyria cutanea tarda.
Porphyria Cutanea Tarda
Erythrocyte porphyrinogen carboxy-lyase activity in porphyria cutanea tarda and certain other human porphyrias.
Porphyria Cutanea Tarda
Erythrocyte uroporphyrinogen decarboxylase activity in 80 unrelated patients with porphyria cutanea tarda.
Porphyria Cutanea Tarda
Erythrocyte uroporphyrinogen decarboxylase activity in porphyria cutanea tarda: a study of 40 consecutive patients.
Porphyria Cutanea Tarda
Erythrocyte uroporphyrinogen decarboxylase activity: diagnostic value and relationship with clinical features in hereditary porphyria cutanea tarda.
Porphyria Cutanea Tarda
Expression and characterization of six clinically relevant uroporphyrinogen decarboxylase gene mutations.
Porphyria Cutanea Tarda
Familial and sporadic porphyria cutanea tarda: characterization and diagnostic strategies.
Porphyria Cutanea Tarda
Familial and sporadic porphyria cutanea tarda: clinical, biochemical and genetic features with emphasis on iron status.
Porphyria Cutanea Tarda
Familial porphyria cutanea tarda in Spain: characterization of eight novel mutations in the UROD gene and haplotype analysis of the common p.G281E mutation.
Porphyria Cutanea Tarda
Familial porphyria cutanea tarda with normal erythrocytic urodecarboxylase: an exception to the rule?
Porphyria Cutanea Tarda
Familial porphyria cutanea tarda: characterization of seven novel uroporphyrinogen decarboxylase mutations and frequency of common hemochromatosis alleles.
Porphyria Cutanea Tarda
Familial porphyria cutanea tarda: hybridization analysis of the uroporphyrinogen decarboxylase locus.
Porphyria Cutanea Tarda
Familial porphyria cutanea tarda: the pattern of porphyrins formed from porphobilinogen by hemolysates.
Porphyria Cutanea Tarda
Functional consequences of naturally occurring mutations in human uroporphyrinogen decarboxylase.
Porphyria Cutanea Tarda
Genetics and pathogenesis of human uroporphyrinogen decarboxylase defects.
Porphyria Cutanea Tarda
Haem biosynthesis and human porphyria cutanea tarda: effects of alcohol intake.
Porphyria Cutanea Tarda
Hemochromatosis (HFE) and transferrin receptor-1 (TFRC1) genes in sporadic porphyria cutanea tarda (sPCT).
Porphyria Cutanea Tarda
Hemochromatosis gene sequence deviations in German patients with porphyria cutanea tarda.
Porphyria Cutanea Tarda
Hemorheological status and redox homeostasis of phlebotomised porphyria cutanea tarda patients with diabetes mellitus and in moderate alcohol consumer.
Porphyria Cutanea Tarda
Hepatic heme synthesis in a new model of experimental hemochromatosis: studies in rats fed finely divided elemental iron.
Porphyria Cutanea Tarda
Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infection.
Porphyria Cutanea Tarda
Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association.
Porphyria Cutanea Tarda
Hepatitis C virus core protein triggers abnormal porphyrin metabolism in human hepatocellular carcinoma cells.
Porphyria Cutanea Tarda
Hepatoerythropoietic porphyria and familial porphyria cutanea tarda in Spanish patients: G281E mutation in the uroporphyrinogen decarboxylase gene.
Porphyria Cutanea Tarda
Hepatoerythropoietic porphyria: a missense mutation in the UROD gene is associated with mild disease and an unusual porphyrin excretion pattern.
Porphyria Cutanea Tarda
Hepatoerythropoietic porphyria: a new uroporphyrinogen decarboxylase defect or homozygous porphyria cutanea tarda?
Porphyria Cutanea Tarda
Hereditary uroporphyrinogen-decarboxylase deficiency predisposing porphyria cutanea tarda (chronic hepatic porphyria) in females after oral contraceptive medication.
Porphyria Cutanea Tarda
Heterozygosity for HLA-linked hemochromatosis as a likely cause of the hepatic siderosis associated with sporadic porphyria cutanea tarda.
Porphyria Cutanea Tarda
HFE mutations and transferrin receptor polymorphism analysis in porphyria cutanea tarda: a prospective study of 36 cases from southern France.
Porphyria Cutanea Tarda
High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda.
Porphyria Cutanea Tarda
High-dose vitamin E lowers urine porphyrin levels in patients affected by porphyria cutanea tarda.
Porphyria Cutanea Tarda
How does hexachlorobenzene treatment affect liver uroporphyrinogen decarboxylase?
Porphyria Cutanea Tarda
Identification and characterization of novel uroporphyrinogen decarboxylase gene mutations in a large series of porphyria cutanea tarda patients and relatives.
Porphyria Cutanea Tarda
Identification of a mutation in the ovine uroporphyrinogen decarboxylase (UROD) gene associated with a type of porphyria.
Porphyria Cutanea Tarda
Identification of a new mutation responsible for hepatoerythropoietic porphyria.
Porphyria Cutanea Tarda
Identification of two types of porphyria cutanea tarda by measurement of erythrocyte uroporphyrinogen decarboxylase.
Porphyria Cutanea Tarda
Immunoreactive uroporphyrinogen decarboxylase in porphyria cutanea tarda.
Porphyria Cutanea Tarda
Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda.
Porphyria Cutanea Tarda
Incidence of hereditary porphyria cutanea tarda (PCT) in a sample of the Italian population.
Porphyria Cutanea Tarda
Levels of uroporphyrinogen decarboxylase (URO-D) in erythrocytes of Italian porphyria cutanea tarda patients.
Porphyria Cutanea Tarda
Liver cirrhosis induced by porphyria cutanea tarda: a case report and review.
Porphyria Cutanea Tarda
Low-Dose Hydroxychloroquine is as Effective as Phlebotomy in Treatment of Patients with Porphyria Cutanea Tarda.
Porphyria Cutanea Tarda
Major and trace elements in whole blood of phlebotomized patients with porphyria cutanea tarda.
Porphyria Cutanea Tarda
Modified uroporphyrinogen decarboxylase activity in a yeast mutant which mimics porphyria cutanea tarda.
Porphyria Cutanea Tarda
Molecular analysis of the UROD gene in 17 Argentinean patients with familial porphyria cutanea tarda: Characterization of four novel mutations.
Porphyria Cutanea Tarda
Molecular heterogeneity of familial porphyria cutanea tarda in Spain: characterization of 10 novel mutations in the UROD gene.
Porphyria Cutanea Tarda
Mouse uroporphyrinogen decarboxylase: cDNA cloning, expression, and mapping.
Porphyria Cutanea Tarda
Murine models of the human porphyrias: Contributions toward understanding disease pathogenesis and the development of new therapies.
Porphyria Cutanea Tarda
Mutations in familial porphyria cutanea tarda: two novel and two previously described for hepatoerythropoietic porphyria.
Porphyria Cutanea Tarda
Paraneoplastic porphyria cutanea tarda associated with cholangiocarcinoma: Case report.
Porphyria Cutanea Tarda
Porphyria cutanea tarda and hepatoerythropoietic porphyria: Identification of 19 novel uroporphyrinogen III decarboxylase mutations.
Porphyria Cutanea Tarda
Porphyria cutanea tarda and HLA-linked hemochromatosis. Evidence against a systematic association.
Porphyria Cutanea Tarda
Porphyria cutanea tarda associated with HFE C282Y homozygosity, iron overload, and use of a contraceptive vaginal ring.
Porphyria Cutanea Tarda
Porphyria cutanea tarda in a patient on chronic ambulatory peritoneal dialysis.
Porphyria Cutanea Tarda
Porphyria cutanea tarda in human immunodeficiency virus-seropositive men: case report and literature review.
Porphyria Cutanea Tarda
Porphyria cutanea tarda increases risk of hepatocellular carcinoma and premature death: a nationwide cohort study.
Porphyria Cutanea Tarda
Porphyria cutanea tarda, hepatitis C, uroporphyrinogen decarboxylase and mutations of HFE gene. A case-control study.
Porphyria Cutanea Tarda
Porphyria cutanea tarda, or the uroporphyrinogen decarboxylase deficiency diseases.
Porphyria Cutanea Tarda
Porphyria cutanea tarda: erythrocyte uroporphyrinogen decarboxylase activity in 471 consecutive patients.
Porphyria Cutanea Tarda
Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency.
Porphyria Cutanea Tarda
Precipitating factors of porphyria cutanea tarda in Brazil with emphasis on hemochromatosis gene (HFE) mutations. Study of 60 patients.
Porphyria Cutanea Tarda
Precipitating/aggravating factors of porphyria cutanea tarda in Spanish patients.
Porphyria Cutanea Tarda
Purification and properties of human erythrocyte uroporphyrinogen decarboxylase: immunological demonstration of the enzyme defect in porphyria cutanea tarda.
Porphyria Cutanea Tarda
Red-cell uroporphyrinogen decarboxylase activity in porphyria cutanea tarda and in other forms of porphyria.
Porphyria Cutanea Tarda
Reduced substrate affinity for human erythrocyte uroporphyrinogen decarboxylase constitutes the inherent biochemical defect in porphyria cutanea tarda.
Porphyria Cutanea Tarda
Screening for mutations in the uroporphyrinogen decarboxylase gene using denaturing gradient gel electrophoresis. Identification and characterization of six novel mutations associated with familial PCT.
Porphyria Cutanea Tarda
Seven novel point mutations in the uroporphyrinogen decarboxylase (UROD) gene in patients with familial porphyria cutanea tarda (f-PCT).
Porphyria Cutanea Tarda
Smoking but not homozygosity for CYP1A2 g-163A allelic variant leads to earlier disease onset in patients with sporadic porphyria cutanea tarda.
Porphyria Cutanea Tarda
Sporadic Porphyria in a patient with stage II melanoma treated with interferon ?.
Porphyria Cutanea Tarda
Steady-state levels of uroporphyrinogen decarboxylase mRNA in lymphoblastoid cell lines from patients with familial porphyria cutanea tarda and their relatives.
Porphyria Cutanea Tarda
Structural and kinetic characterization of mutant human uroporphyrinogen decarboxylases.
Porphyria Cutanea Tarda
The association of hepatitis C viral infection with porphyria cutanea tarda in the Lothian region of Scotland.
Porphyria Cutanea Tarda
The enzymatic defects in porphyria cutanea tarda and variegate porphyria.
Porphyria Cutanea Tarda
The molecular basis of porphyria cutanea tarda in Chile: identification and functional characterization of mutations in the uroporphyrinogen decarboxylase gene.
Porphyria Cutanea Tarda
The role of iron in experimental porphyria and porphyria cutanea tarda.
Porphyria Cutanea Tarda
The role of iron in the pathogenesis of porphyria cutanea tarda. II. Inhibition of uroporphyrinogen decarboxylase.
Porphyria Cutanea Tarda
Three new mutations in the uroporphyrinogen decarboxylase gene in familial porphyria cutanea tarda. Mutation in brief no. 237. Online.
Porphyria Cutanea Tarda
Two cases of infantile porphyria cutanea tarda: successful treatment with oral S-adenosyl-L-methionine and low-dose oral chloroquine.
Porphyria Cutanea Tarda
Uroporphyrinogen decarboxylase gene mutations in Danish patients with porphyria cutanea tarda.
Porphyria Cutanea Tarda
Uroporphyrinogen decarboxylase structural mutant (Gly281----Glu) in a case of porphyria.
Porphyria Cutanea Tarda
Uroporphyrinogen decarboxylase: a splice site mutation causes the deletion of exon 6 in multiple families with porphyria cutanea tarda.
Porphyria Cutanea Tarda
Uroporphyrinogen decarboxylase: complete human gene sequence and molecular study of three families with hepatoerythropoietic porphyria.
Porphyria Cutanea Tarda
Volatile anaesthetics induce biochemical alterations in the heme pathway in a B-lymphocyte cell line established from hepatoerythropoietic porphyria patients (LBHEP) and in mice inoculated with LBHEP cells.
Porphyria Cutanea Tarda
[Acquired characteristics of porphyria cutanea tarda in patients infected with hepatitis C virus]
Porphyria Cutanea Tarda
[Association of idiopathic hemochromatosis and tardive cutaneous porphyria]
Porphyria Cutanea Tarda
[Decreased erythrocyte uroporphyrinogen decarboxylase activity in porphyria cutanea tarda]
Porphyria Cutanea Tarda
[Hepatocellular carcinoma associated to porphyria cutanea tarda and hepatitis C virus infection without cirrhosis]
Porphyria Cutanea Tarda
[Hereditary porphyria cutanea in children. Enzymatic studies (author's transl)]
Porphyria Cutanea Tarda
[Hereditary uroporphyrinogen decarboxylase deficiency in porphyria cutanea tarda caused by hormonal contraceptives]
Porphyria Cutanea Tarda
[Porphyria cutanea tarda in a 4-year-old child with uroporphyrinogen decarboxylase deficiency]
Porphyria Cutanea Tarda
[Porphyria cutanea tarda in a hemodialysed patient with hepatitis C virus infection: efficacy treatment by small repeated phlebotomies]
Porphyria Cutanea Tarda
[Porphyria cutanea tarda, pseudoporphyria and hemodialysis of chronic renal failure patients]
Porphyria Cutanea Tarda
[Significance and prevalence of the C282Y gene mutation of primary hemochromatosis in the pathogenesis of pophyria cutanea tarda]
Porphyria Cutanea Tarda
[Significance of metal ion metabolism and oxidative stress in male patients with porphyria cutanea tarda.]
Porphyria Cutanea Tarda
[Uroporphyrinogen decarboxylase in erythrocytes: studies on the primary genetic enzyme defect in chronic hepatic porphyria (author's transl)]
Porphyria, Erythropoietic
Coexistence of deficiencies of uroporphyrinogen III synthase and decarboxylase in a patient with congenital erythropoietic porphyria and in his family.
Porphyria, Erythropoietic
Congenital erythropoietic porphyria, diminished activity of uroporphyrinogen decarboxylase and dyserythropoiesis.
Porphyria, Erythropoietic
Porphyrins in urine, plasma, erythrocytes, bile and faeces in a case of congenital erythropoietic porphyria (Gunther's disease) treated with blood transfusion and iron chelation: lack of benefit from oral charcoal.
Porphyria, Hepatoerythropoietic
A mutation (G281E) of the human uroporphyrinogen decarboxylase gene causes both hepatoerythropoietic porphyria and overt familial porphyria cutanea tarda: biochemical and genetic studies on Spanish patients.
Porphyria, Hepatoerythropoietic
Characterization of a new mutation (R292G) and a deletion at the human uroporphyrinogen decarboxylase locus in two patients with hepatoerythropoietic porphyria.
Porphyria, Hepatoerythropoietic
Correction of uroporphyrinogen decarboxylase deficiency (hepatoerythropoietic porphyria) in Epstein-Barr virus-transformed B-cell lines by retrovirus-mediated gene transfer: fluorescence-based selection of transduced cells.
Porphyria, Hepatoerythropoietic
Enzymatic and immunological studies of uroporphyrinogen decarboxylase in familial porphyria cutanea tarda and hepatoerythropoietic porphyria.
Porphyria, Hepatoerythropoietic
Erythrocyte uroporphyrinogen decarboxylase activity: diagnostic value and relationship with clinical features in hereditary porphyria cutanea tarda.
Porphyria, Hepatoerythropoietic
Genetics and pathogenesis of human uroporphyrinogen decarboxylase defects.
Porphyria, Hepatoerythropoietic
Hematologic and hepatic manifestations of the cutaneous porphyrias.
Porphyria, Hepatoerythropoietic
Hepatoerythropoietic porphyria and familial porphyria cutanea tarda in Spanish patients: G281E mutation in the uroporphyrinogen decarboxylase gene.
Porphyria, Hepatoerythropoietic
Hepatoerythropoietic Porphyria Caused by a Novel Homoallelic Mutation in Uroporphyrinogen Decarboxylase Gene in Egyptian Patients.
Porphyria, Hepatoerythropoietic
Hepatoerythropoietic porphyria due to a novel mutation in the uroporphyrinogen decarboxylase gene.
Porphyria, Hepatoerythropoietic
Hepatoerythropoietic porphyria misdiagnosed as child abuse: cutaneous, arthritic, and hematologic manifestations in siblings with a novel UROD mutation.
Porphyria, Hepatoerythropoietic
Hepatoerythropoietic porphyria precipitated by viral hepatitis.
Porphyria, Hepatoerythropoietic
Hepatoerythropoietic porphyria: a missense mutation in the UROD gene is associated with mild disease and an unusual porphyrin excretion pattern.
Porphyria, Hepatoerythropoietic
Hepatoerythropoietic porphyria: a new uroporphyrinogen decarboxylase defect or homozygous porphyria cutanea tarda?
Porphyria, Hepatoerythropoietic
Hepatoerythropoietic porphyria: a variant of childhood-onset porphyria cutanea tarda. Porphyrin profiles and enzymatic studies of two cases in a family.
Porphyria, Hepatoerythropoietic
Hepatoerythropoietic porphyria: clinical, biochemical, and enzymatic studies in a three-generation family lineage.
Porphyria, Hepatoerythropoietic
Identification of a new mutation responsible for hepatoerythropoietic porphyria.
Porphyria, Hepatoerythropoietic
Immunochemical study of uroporphyrinogen decarboxylase in a patient with mild hepatoerythropoietic porphyria.
Porphyria, Hepatoerythropoietic
Is hepatoerythropoietic porphyria a homozygous form of porphyria cutanea tarda? Inheritance of uroporphyrinogen decarboxylase deficiency in a Spanish family.
Porphyria, Hepatoerythropoietic
Molecular analysis of uroporphyrinogen decarboxylase deficiency in a family with two cases of hepatoerythropoietic porphyria.
Porphyria, Hepatoerythropoietic
Molecular defects of uroporphyrinogen decarboxylase in a patient with mild hepatoerythropoietic porphyria.
Porphyria, Hepatoerythropoietic
Mutations in familial porphyria cutanea tarda: two novel and two previously described for hepatoerythropoietic porphyria.
Porphyria, Hepatoerythropoietic
Neurologic disease in a child with hepatoerythropoietic porphyria.
Porphyria, Hepatoerythropoietic
Porphyria cutanea tarda and hepatoerythropoietic porphyria: Identification of 19 novel uroporphyrinogen III decarboxylase mutations.
Porphyria, Hepatoerythropoietic
Screening for mutations in the uroporphyrinogen decarboxylase gene using denaturing gradient gel electrophoresis. Identification and characterization of six novel mutations associated with familial PCT.
Porphyria, Hepatoerythropoietic
Two novel uroporphyrinogen decarboxylase (URO-D) mutations causing hepatoerythropoietic porphyria (HEP).
Porphyria, Hepatoerythropoietic
Uroporphyrinogen decarboxylase deficiency in hepatoerythropoietic porphyria: further evidence for genetic heterogeneity.
Porphyria, Hepatoerythropoietic
Uroporphyrinogen decarboxylase structural mutant (Gly281----Glu) in a case of porphyria.
Porphyria, Hepatoerythropoietic
Uroporphyrinogen decarboxylase: complete human gene sequence and molecular study of three families with hepatoerythropoietic porphyria.
Porphyria, Hepatoerythropoietic
Volatile anaesthetics induce biochemical alterations in the heme pathway in a B-lymphocyte cell line established from hepatoerythropoietic porphyria patients (LBHEP) and in mice inoculated with LBHEP cells.
Porphyria, Variegate
Erythrocyte porphyrinogen carboxy-lyase activity in porphyria cutanea tarda and certain other human porphyrias.
Porphyrias
2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced porphyria in genetically inbred mice: partial antagonism and mechanistic studies.
Porphyrias
A case of porphyria cutanea tarda in the setting of hepatitis C infection and tobacco usage.
Porphyrias
A first report of porphyria cutanea tarda successfully treated with glycyrrhizin.
Porphyrias
A mutation (G281E) of the human uroporphyrinogen decarboxylase gene causes both hepatoerythropoietic porphyria and overt familial porphyria cutanea tarda: biochemical and genetic studies on Spanish patients.
Porphyrias
A point mutation in the coding region of uroporphyrinogen decarboxylase associated with familial porphyria cutanea tarda.
Porphyrias
A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda.
Porphyrias
A potential biochemical explanation for the genesis of porphyria cutanea tarda. Studies on the inherent biochemical defect in highly purified human erythrocyte uroporphyrinogen decarboxylase and its amplification by iron.
Porphyrias
A simplified method for determination of uroporphyrinogen decarboxylase activity in human blood.
Porphyrias
Abnormal kinetic behavior of uroporphyrinogen decarboxylase obtained from rats with hexachlorobenzene-induced porphyria.
Porphyrias
Accumulation of uroporphyrin does not provoke further inhibition of liver uroporphyrinogen decarboxylase activity in hexachlorobenzene-induced porphyria.
Porphyrias
Activation of uroporphyrinogen decarboxylase by ferrous iron in porphyria cutanea tarda.
Porphyrias
An inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyrinogen decarboxylase activity.
Porphyrias
Analysis of uroporphyrinogen decarboxylase complementary DNAs in sporadic porphyria cutanea tarda.
Porphyrias
Associations among behavior-related susceptibility factors in porphyria cutanea tarda.
Porphyrias
Bilateral, geographic, peripapillary, chorioretinal atrophy in a patient with porphyria cutanea tarda and high iron stores.
Porphyrias
Blistering Disease During the Treatment of Chronic Hepatitis C With Ledipasvir/Sofosbuvir.
Porphyrias
C282Y and H63D mutation of the hemochromatosis gene in German porphyria cutanea tarda patients.
Porphyrias
Characterization of a new mutation (R292G) and a deletion at the human uroporphyrinogen decarboxylase locus in two patients with hepatoerythropoietic porphyria.
Porphyrias
Childhood-onset mild cutaneous porphyria with compound heterozygotic mutations in the uroporphyrinogen decarboxylase gene.
Porphyrias
Co-inheritance of mutations in the uroporphyrinogen decarboxylase and hemochromatosis genes accelerates the onset of porphyria cutanea tarda.
Porphyrias
Complex pattern of alternative splicing in the normal uroporphyrinogen decarboxylase gene: implications for diagnosis of familial porphyria cutanea tarda.
Porphyrias
Comprehensive cytochrome P450 CYP1A2 gene analysis in French caucasian patients with familial and sporadic porphyria cutanea tarda.
Porphyrias
CYP1A2*1F and GSTM1 Alleles Are Associated with Susceptibility to Porphyria Cutanea Tarda.
Porphyrias
Cytochrome P450 induction, uroporphyrinogen decarboxylase depression, porphyrin accumulation and excretion, and gender influence in a 3-week rat model of porphyria cutanea tarda.
Porphyrias
Decreased activity of hepatic uroporphyrinogen decarboxylase in sporadic porphyria cutanea tarda.
Porphyrias
Decreased hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda.
Porphyrias
Defective human erythrocyte uroporphyrinogen decarboxylase in familial porphyria cutanea tarda: the metabolic lesion or the result of endogenous porphyrinemia?
Porphyrias
Direct Assay of Enzymes in Heme Biosynthesis for the Detection of Porphyrias by Tandem Mass Spectrometry. Uroporphyrinogen Decarboxylase and Coproporphyrinogen III Oxidase.
Porphyrias
Distinction between octachlorostyrene and hexachlorobenzene in their potentials to induce ethoxyphenoxazone deethylase and cause porphyria in rats and mice.
Porphyrias
Dual mechanism of inhibition of rat liver uroporphyrinogen decarboxylase activity by ferrous iron: its potential role in the genesis of porphyria cutanea tarda.
Porphyrias
Dual porphyria in double heterozygotes with porphobilinogen deaminase and uroporphyrinogen decarboxylase deficiencies.
Porphyrias
Effects of hexachlorobenzene feeding and iron overload on enzymes of haem biosynthesis and cytochrome P 450 in rat liver.
Porphyrias
Effects of polychlorinated biphenyl compounds, 2,3,7,8-tetrachlorodibenzo-p-dioxin, phenobarbital and iron on hepatic uroporphyrinogen decarboxylase. Implications for the pathogenesis of porphyria.
Porphyrias
Enzymatic and immunological studies of uroporphyrinogen decarboxylase in familial porphyria cutanea tarda and hepatoerythropoietic porphyria.
Porphyrias
Erythrocyte porphyrinogen carboxy-lyase activity in porphyria cutanea tarda and certain other human porphyrias.
Porphyrias
Erythrocyte uroporphyrinogen decarboxylase activity in 80 unrelated patients with porphyria cutanea tarda.
Porphyrias
Erythrocyte uroporphyrinogen decarboxylase activity in porphyria cutanea tarda: a study of 40 consecutive patients.
Porphyrias
Erythrocyte uroporphyrinogen decarboxylase activity: diagnostic value and relationship with clinical features in hereditary porphyria cutanea tarda.
Porphyrias
Expression and characterization of six clinically relevant uroporphyrinogen decarboxylase gene mutations.
Porphyrias
Familial and sporadic porphyria cutanea tarda: characterization and diagnostic strategies.
Porphyrias
Familial and sporadic porphyria cutanea tarda: clinical, biochemical and genetic features with emphasis on iron status.
Porphyrias
Familial porphyria cutanea tarda in Spain: characterization of eight novel mutations in the UROD gene and haplotype analysis of the common p.G281E mutation.
Porphyrias
Familial porphyria cutanea tarda with normal erythrocytic urodecarboxylase: an exception to the rule?
Porphyrias
Familial porphyria cutanea tarda: characterization of seven novel uroporphyrinogen decarboxylase mutations and frequency of common hemochromatosis alleles.
Porphyrias
Familial porphyria cutanea tarda: hybridization analysis of the uroporphyrinogen decarboxylase locus.
Porphyrias
Familial porphyria cutanea tarda: the pattern of porphyrins formed from porphobilinogen by hemolysates.
Porphyrias
Five new mutations in the uroporphyrinogen decarboxylase gene identified in families with cutaneous porphyria.
Porphyrias
Functional consequences of naturally occurring mutations in human uroporphyrinogen decarboxylase.
Porphyrias
Hemochromatosis (HFE) and transferrin receptor-1 (TFRC1) genes in sporadic porphyria cutanea tarda (sPCT).
Porphyrias
Hemochromatosis gene sequence deviations in German patients with porphyria cutanea tarda.
Porphyrias
Hemorheological status and redox homeostasis of phlebotomised porphyria cutanea tarda patients with diabetes mellitus and in moderate alcohol consumer.
Porphyrias
Hepatic heme synthesis in a new model of experimental hemochromatosis: studies in rats fed finely divided elemental iron.
Porphyrias
Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infection.
Porphyrias
Hepatitis C virus core protein triggers abnormal porphyrin metabolism in human hepatocellular carcinoma cells.
Porphyrias
Hepatocarcinogenicity of hexachlorobenzene in rats and the sex difference in hepatic iron status and development of porphyria.
Porphyrias
Hepatoerythropoietic porphyria and familial porphyria cutanea tarda in Spanish patients: G281E mutation in the uroporphyrinogen decarboxylase gene.
Porphyrias
Hepatoerythropoietic porphyria due to a novel mutation in the uroporphyrinogen decarboxylase gene.
Porphyrias
Hepatoerythropoietic porphyria: a missense mutation in the UROD gene is associated with mild disease and an unusual porphyrin excretion pattern.
Porphyrias
Hepatoerythropoietic porphyria: a new uroporphyrinogen decarboxylase defect or homozygous porphyria cutanea tarda?
Porphyrias
Hereditary uroporphyrinogen-decarboxylase deficiency predisposing porphyria cutanea tarda (chronic hepatic porphyria) in females after oral contraceptive medication.
Porphyrias
Heterozygosity for HLA-linked hemochromatosis as a likely cause of the hepatic siderosis associated with sporadic porphyria cutanea tarda.
Porphyrias
HFE mutations and transferrin receptor polymorphism analysis in porphyria cutanea tarda: a prospective study of 36 cases from southern France.
Porphyrias
High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda.
Porphyrias
High-dose vitamin E lowers urine porphyrin levels in patients affected by porphyria cutanea tarda.
Porphyrias
How does hexachlorobenzene treatment affect liver uroporphyrinogen decarboxylase?
Porphyrias
Identification and characterization of novel uroporphyrinogen decarboxylase gene mutations in a large series of porphyria cutanea tarda patients and relatives.
Porphyrias
Identification of a mutation in the ovine uroporphyrinogen decarboxylase (UROD) gene associated with a type of porphyria.
Porphyrias
Identification of two types of porphyria cutanea tarda by measurement of erythrocyte uroporphyrinogen decarboxylase.
Porphyrias
Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda.
Porphyrias
Immunoreactive uroporphyrinogen decarboxylase is unchanged in porphyria caused by TCDD and hexachlorobenzene.
Porphyrias
Incidence of hereditary porphyria cutanea tarda (PCT) in a sample of the Italian population.
Porphyrias
Iron and uroporphyrin in hepatocytes of inbred mice in experimental porphyria: a biochemical and morphological study.
Porphyrias
Is hepatoerythropoietic porphyria a homozygous form of porphyria cutanea tarda? Inheritance of uroporphyrinogen decarboxylase deficiency in a Spanish family.
Porphyrias
Levels of uroporphyrinogen decarboxylase (URO-D) in erythrocytes of Italian porphyria cutanea tarda patients.
Porphyrias
Low-Dose Hydroxychloroquine is as Effective as Phlebotomy in Treatment of Patients with Porphyria Cutanea Tarda.
Porphyrias
Major and trace elements in whole blood of phlebotomized patients with porphyria cutanea tarda.
Porphyrias
Modified uroporphyrinogen decarboxylase activity in a yeast mutant which mimics porphyria cutanea tarda.
Porphyrias
Molecular analysis of the UROD gene in 17 Argentinean patients with familial porphyria cutanea tarda: Characterization of four novel mutations.
Porphyrias
Molecular heterogeneity of familial porphyria cutanea tarda in Spain: characterization of 10 novel mutations in the UROD gene.
Porphyrias
Murine models of the human porphyrias: Contributions toward understanding disease pathogenesis and the development of new therapies.
Porphyrias
Mutations in familial porphyria cutanea tarda: two novel and two previously described for hepatoerythropoietic porphyria.
Porphyrias
Oxidation of uroporphyrinogens by hydroxyl radicals. Evidence for nonporphyrin products as potential inhibitors of uroporphyrinogen decarboxylase.
Porphyrias
Paraneoplastic porphyria cutanea tarda associated with cholangiocarcinoma: Case report.
Porphyrias
Polycyclic aromatic hydrocarbons cause hepatic porphyria in iron-loaded C57BL/10 mice: comparison of uroporphyrinogen decarboxylase inhibition with induction of alkoxyphenoxazone dealkylations.
Porphyrias
Porphyria cutanea tarda and hepatoerythropoietic porphyria: Identification of 19 novel uroporphyrinogen III decarboxylase mutations.
Porphyrias
Porphyria cutanea tarda and HLA-linked hemochromatosis. Evidence against a systematic association.
Porphyrias
Porphyria cutanea tarda associated with HFE C282Y homozygosity, iron overload, and use of a contraceptive vaginal ring.
Porphyrias
Porphyria cutanea tarda in human immunodeficiency virus-seropositive men: case report and literature review.
Porphyrias
Porphyria cutanea tarda increases risk of hepatocellular carcinoma and premature death: a nationwide cohort study.
Porphyrias
Porphyria cutanea tarda, hepatitis C, uroporphyrinogen decarboxylase and mutations of HFE gene. A case-control study.
Porphyrias
Porphyria cutanea tarda, or the uroporphyrinogen decarboxylase deficiency diseases.
Porphyrias
Porphyria cutanea tarda: erythrocyte uroporphyrinogen decarboxylase activity in 471 consecutive patients.
Porphyrias
Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency.
Porphyrias
Precipitating factors of porphyria cutanea tarda in Brazil with emphasis on hemochromatosis gene (HFE) mutations. Study of 60 patients.
Porphyrias
Precipitating/aggravating factors of porphyria cutanea tarda in Spanish patients.
Porphyrias
Purification and properties of human erythrocyte uroporphyrinogen decarboxylase: immunological demonstration of the enzyme defect in porphyria cutanea tarda.
Porphyrias
Rat-liver porphyrinogen carboxy-lyase inhibition as a function of the degree of hexachlorobenzene-induced porphyria.
Porphyrias
Red-cell uroporphyrinogen decarboxylase activity in porphyria cutanea tarda and in other forms of porphyria.
Porphyrias
Reduced substrate affinity for human erythrocyte uroporphyrinogen decarboxylase constitutes the inherent biochemical defect in porphyria cutanea tarda.
Porphyrias
Relative abilities on a molar basis of hexafluoro-, hexachloro- and hexabromobenzenes to decrease liver uroporphyrinogen decarboxylase activity and cause porphyria in female rats.
Porphyrias
Role of inhibition of uroporphyrinogen decarboxylase in PCB-induced porphyria in mice.
Porphyrias
Screening for mutations in the uroporphyrinogen decarboxylase gene using denaturing gradient gel electrophoresis. Identification and characterization of six novel mutations associated with familial PCT.
Porphyrias
Seven novel point mutations in the uroporphyrinogen decarboxylase (UROD) gene in patients with familial porphyria cutanea tarda (f-PCT).
Porphyrias
Smoking but not homozygosity for CYP1A2 g-163A allelic variant leads to earlier disease onset in patients with sporadic porphyria cutanea tarda.
Porphyrias
Sporadic Porphyria in a patient with stage II melanoma treated with interferon ?.
Porphyrias
Steady-state levels of uroporphyrinogen decarboxylase mRNA in lymphoblastoid cell lines from patients with familial porphyria cutanea tarda and their relatives.
Porphyrias
Structural and kinetic characterization of mutant human uroporphyrinogen decarboxylases.
Porphyrias
Studies on the mechanism of uroporphyrinogen decarboxylase inhibition in hexachlorobenzene-induced porphyria in the female rat.
Porphyrias
Synergy of iron in the toxicity and carcinogenicity of polychlorinated biphenyls (PCBs) and related chemicals.
Porphyrias
The association of hepatitis C viral infection with porphyria cutanea tarda in the Lothian region of Scotland.
Porphyrias
The decrease in uroporphyrinogen decarboxylase activity induced by ethanol predisposes rats to the development of porphyria and accelerates xenobiotic-triggered porphyria, regardless of hepatic damage.
Porphyrias
The effect of the porphyrogenic compound, hexachlorobenzene, on the activity of hepatic uroporphyrinogen decarboxylase in the rat.
Porphyrias
The involvement of iron and lipid peroxidation in the pathogenesis of HCB induced porphyria.
Porphyrias
The molecular basis of porphyria cutanea tarda in Chile: identification and functional characterization of mutations in the uroporphyrinogen decarboxylase gene.
Porphyrias
The role of iron in the hexachlorobenzene induced porphyria. I. Studies on different types of iron and its relation with porphyrinogen carboxy-lyase decrease.
Porphyrias
The role of iron in the pathogenesis of porphyria cutanea tarda. II. Inhibition of uroporphyrinogen decarboxylase.
Porphyrias
Three new mutations in the uroporphyrinogen decarboxylase gene in familial porphyria cutanea tarda. Mutation in brief no. 237. Online.
Porphyrias
Two cases of infantile porphyria cutanea tarda: successful treatment with oral S-adenosyl-L-methionine and low-dose oral chloroquine.
Porphyrias
Uroporphyrinogen decarboxylase gene mutations in Danish patients with porphyria cutanea tarda.
Porphyrias
Uroporphyrinogen decarboxylase structural mutant (Gly281----Glu) in a case of porphyria.
Porphyrias
Uroporphyrinogen decarboxylase: a splice site mutation causes the deletion of exon 6 in multiple families with porphyria cutanea tarda.
Porphyrias
Uroporphyrinogen decarboxylase: complete human gene sequence and molecular study of three families with hepatoerythropoietic porphyria.
Porphyrias
Volatile anaesthetics induce biochemical alterations in the heme pathway in a B-lymphocyte cell line established from hepatoerythropoietic porphyria patients (LBHEP) and in mice inoculated with LBHEP cells.
Porphyrias
[Acquired characteristics of porphyria cutanea tarda in patients infected with hepatitis C virus]
Porphyrias
[Decreased erythrocyte uroporphyrinogen decarboxylase activity in porphyria cutanea tarda]
Porphyrias
[Enzymatic and molecular studies in a case of hepato-erythropoietic porphyria. Homozygote form of type familial cutaneous porphyria]
Porphyrias
[Experimental porphyria induced by chlorinated hydrocarbons. Studies of porphyrinogen carboxy-lyase in the experimental model of human cutaneous delayed porphyria]
Porphyrias
[Hepatocellular carcinoma associated to porphyria cutanea tarda and hepatitis C virus infection without cirrhosis]
Porphyrias
[Hereditary uroporphyrinogen decarboxylase deficiency in porphyria cutanea tarda caused by hormonal contraceptives]
Porphyrias
[Porphyria cutanea tarda in a 4-year-old child with uroporphyrinogen decarboxylase deficiency]
Porphyrias
[Porphyria cutanea tarda in a hemodialysed patient with hepatitis C virus infection: efficacy treatment by small repeated phlebotomies]
Porphyrias
[Porphyria cutanea tarda, pseudoporphyria and hemodialysis of chronic renal failure patients]
Porphyrias
[Significance and prevalence of the C282Y gene mutation of primary hemochromatosis in the pathogenesis of pophyria cutanea tarda]
Porphyrias
[Significance of metal ion metabolism and oxidative stress in male patients with porphyria cutanea tarda.]
Porphyrias
[Uroporphyrinogen decarboxylase in erythrocytes: studies on the primary genetic enzyme defect in chronic hepatic porphyria (author's transl)]
Porphyrias, Hepatic
Development of chronic hepatic porphyria (porphyria cutanea tarda) with inherited uroporphyrinogen decarboxylase deficiency under exposure to dioxin.
Porphyrias, Hepatic
Haem biosynthesis in cutaneous hepatic porphyria: comparison with alcoholism and liver disease.
Porphyrias, Hepatic
Hereditary uroporphyrinogen-decarboxylase deficiency predisposing porphyria cutanea tarda (chronic hepatic porphyria) in females after oral contraceptive medication.
Porphyrias, Hepatic
Polycyclic aromatic hydrocarbons cause hepatic porphyria in iron-loaded C57BL/10 mice: comparison of uroporphyrinogen decarboxylase inhibition with induction of alkoxyphenoxazone dealkylations.
Porphyrias, Hepatic
Uroporphyrinogen decarboxylase deficiency in experimental chronic hepatic porphyria.
Porphyrias, Hepatic
Vinyl chloride-induced hepatic coproporphyrinuria with transition to chronic hepatic porphyria.
Porphyrias, Hepatic
[Chronic hepatic porphyria with uroporphyrinogen decarboxylase defect in four generations (author's transl)]
Porphyrias, Hepatic
[Hereditary and non-hereditary form of chronic hepatic porphyria: different behaviour of uroporphyrinogen decarboxylase in liver and erythrocytes (author's transl)]
Porphyrias, Hepatic
[Uroporphyrinogen decarboxylase in erythrocytes: studies on the primary genetic enzyme defect in chronic hepatic porphyria (author's transl)]
Protoporphyria, Erythropoietic
Erythrocyte porphyrinogen carboxy-lyase activity in porphyria cutanea tarda and certain other human porphyrias.
Renal Insufficiency
[Porphyria cutanea tarda, pseudoporphyria and hemodialysis of chronic renal failure patients]
Renal Insufficiency, Chronic
[Porphyria cutanea tarda, pseudoporphyria and hemodialysis of chronic renal failure patients]
Siderosis
An inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyrinogen decarboxylase activity.
Siderosis
Hemochromatosis (HFE) and transferrin receptor-1 (TFRC1) genes in sporadic porphyria cutanea tarda (sPCT).
Siderosis
Heterozygosity for HLA-linked hemochromatosis as a likely cause of the hepatic siderosis associated with sporadic porphyria cutanea tarda.
Skin Diseases
Hemochromatosis (HFE) and transferrin receptor-1 (TFRC1) genes in sporadic porphyria cutanea tarda (sPCT).
uroporphyrinogen decarboxylase deficiency
Correction of uroporphyrinogen decarboxylase deficiency (hepatoerythropoietic porphyria) in Epstein-Barr virus-transformed B-cell lines by retrovirus-mediated gene transfer: fluorescence-based selection of transduced cells.
uroporphyrinogen decarboxylase deficiency
Development of chronic hepatic porphyria (porphyria cutanea tarda) with inherited uroporphyrinogen decarboxylase deficiency under exposure to dioxin.
uroporphyrinogen decarboxylase deficiency
Dual porphyria in double heterozygotes with porphobilinogen deaminase and uroporphyrinogen decarboxylase deficiencies.
uroporphyrinogen decarboxylase deficiency
Enzymatic and immunological studies of uroporphyrinogen decarboxylase in familial porphyria cutanea tarda and hepatoerythropoietic porphyria.
uroporphyrinogen decarboxylase deficiency
Hepatoerythropoietic porphyria precipitated by viral hepatitis.
uroporphyrinogen decarboxylase deficiency
Hepatoerythropoietic porphyria: clinical, biochemical, and enzymatic studies in a three-generation family lineage.
uroporphyrinogen decarboxylase deficiency
Hereditary uroporphyrinogen-decarboxylase deficiency predisposing porphyria cutanea tarda (chronic hepatic porphyria) in females after oral contraceptive medication.
uroporphyrinogen decarboxylase deficiency
Human immunodeficiency virus and risk of porphyria cutanea tarda: a possible association examined in a large hospital.
uroporphyrinogen decarboxylase deficiency
Is hepatoerythropoietic porphyria a homozygous form of porphyria cutanea tarda? Inheritance of uroporphyrinogen decarboxylase deficiency in a Spanish family.
uroporphyrinogen decarboxylase deficiency
Isolation and characterization of extragenic mutations affecting the expression of the uroporphyrinogen decarboxylase gene (HEM12) in Sacharomyces cerevisiae.
uroporphyrinogen decarboxylase deficiency
Molecular analysis of uroporphyrinogen decarboxylase deficiency in a family with two cases of hepatoerythropoietic porphyria.
uroporphyrinogen decarboxylase deficiency
Porphyria cutanea tarda, or the uroporphyrinogen decarboxylase deficiency diseases.
uroporphyrinogen decarboxylase deficiency
Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency.
uroporphyrinogen decarboxylase deficiency
The role of inherited and acquired factors in the development of porphyria cutanea tarda in the Argentinean population.
uroporphyrinogen decarboxylase deficiency
Uroporphyrinogen decarboxylase deficiency in experimental chronic hepatic porphyria.
uroporphyrinogen decarboxylase deficiency
Uroporphyrinogen decarboxylase deficiency in hepatoerythropoietic porphyria: further evidence for genetic heterogeneity.
uroporphyrinogen decarboxylase deficiency
Uroporphyrinogen decarboxylase structural mutant (Gly281----Glu) in a case of porphyria.
uroporphyrinogen decarboxylase deficiency
[Enzymatic and molecular studies in a case of hepato-erythropoietic porphyria. Homozygote form of type familial cutaneous porphyria]
uroporphyrinogen decarboxylase deficiency
[Hereditary uroporphyrinogen decarboxylase deficiency in porphyria cutanea tarda caused by hormonal contraceptives]
uroporphyrinogen decarboxylase deficiency
[Porphyria cutanea tarda in a 4-year-old child with uroporphyrinogen decarboxylase deficiency]
Virus Diseases
Hemochromatosis gene sequence deviations in German patients with porphyria cutanea tarda.
Virus Diseases
Hepatic porphyrin concentration and uroporphyrinogen decarboxylase activity in hepatitis C virus infection.
Virus Diseases
[Acquired characteristics of porphyria cutanea tarda in patients infected with hepatitis C virus]
html completed